{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:30:18Z","timestamp":1786717818232,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0973-1482.172575","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T02:43:41Z","timestamp":1460429021000},"page":"6","source":"Crossref","is-referenced-by-count":13,"title":["Sunitinib-induced thrombotic microangiopathy"],"prefix":"10.4103","volume":"12","author":[{"given":"Kumar","family":"Prabhash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Punatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RushiV","family":"Desphande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.172575-1","first-page":"682","volume-title":"Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib","author":"Boll\u00e9e","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0973-1482.172575-2","first-page":"e39580","volume-title":"Chronic VEGF blockade worsens glomerular injury in the remnant kidney model","author":"Machado","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.172575-3","first-page":"582","volume-title":"Biology of anti-angiogenic therapy-induced thrombotic microangiopathy","author":"Eremina","year":"2010","journal-title":"Semin Nephrol"},{"key":"key-10.4103\/0973-1482.172575-4","first-page":"1129","volume-title":"VEGF inhibition and renal thrombotic microangiopathy","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.172575-5","first-page":"2824","volume-title":"Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice","author":"Ku","year":"2008","journal-title":"Diabetes"},{"key":"key-10.4103\/0973-1482.172575-6","first-page":"1691","volume-title":"Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling","author":"Sison","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/0973-1482.172575-7","first-page":"1144","volume-title":"A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy","author":"Hohenstein","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0973-1482.172575-8","first-page":"1001","volume-title":"Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy","author":"Costero","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0973-1482.172575-9","first-page":"177","volume-title":"Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma","author":"Frangi\u00e9","year":"2007","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0973-1482.172575-10","first-page":"1745","volume-title":"Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome","author":"Kapiteijn","year":"2007","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1482.172575-11","first-page":"e284","volume-title":"Toxicity of sunitinib plus bevacizumab in renal cell carcinoma","author":"Rini","year":"2010","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.172575-12","first-page":"67","volume-title":"Sunitinib induced nephrotic syndrome and thrombotic microangiopathy","author":"Jha","year":"2013","journal-title":"Indian J Nephrol","ISSN":"https:\/\/id.crossref.org\/issn\/0971-4065","issn-type":"print"},{"key":"key-10.4103\/0973-1482.172575-13","first-page":"211","volume-title":"TTP-HUS associated with sunitinib","author":"Choi","year":"2008","journal-title":"Cancer Res Treat"},{"key":"key-10.4103\/0973-1482.172575-14","first-page":"c312","volume-title":"Nephrotoxicities associated with the use of tyrosine kinase inhibitors: A single-center experience and review of the literature","author":"Jhaveri","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"key-10.4103\/0973-1482.172575-15","first-page":"154","volume-title":"Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation","author":"Levey","year":"2008","journal-title":"NDT Plus"},{"key":"key-10.4103\/0973-1482.172575-16","first-page":"e143","volume-title":"Sunitinib-induced microangiopathic hemolytic anemia with fatal outcome","author":"Talebi","year":"2012","journal-title":"Am J Ther"},{"key":"key-10.4103\/0973-1482.172575-17","first-page":"439","volume-title":"VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management","author":"Izzedine","year":"2010","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0973-1482.172575-18","first-page":"437","volume-title":"Factor V Leiden: A genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity","author":"Raife","year":"2002","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.172575-19","first-page":"309","volume-title":"Thrombotic microangiopathies","author":"Halevy","year":"2002","journal-title":"Crit Care Clin"},{"key":"key-10.4103\/0973-1482.172575-20","first-page":"282","volume-title":"A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib","author":"Patel","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0973-1482.172575-21","first-page":"295","volume-title":"The vascular endothelial growth factor receptor inhibitor sunitinib causes a preeclampsia-like syndrome with activation of the endothelin system","author":"Kappers","year":"2011","journal-title":"Hypertension"},{"key":"key-10.4103\/0973-1482.172575-22","first-page":"341","volume-title":"Allergic interstitial nephritis possibly related to sunitinib use","author":"Khurana","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"key":"key-10.4103\/0973-1482.172575-23","first-page":"673","volume-title":"Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: A class effect?","author":"Winn","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0973-1482.172575-24","first-page":"172","volume-title":"Nephrotic syndrome and acute renal failure apparently induced by sunitinib","author":"Chen","year":"2009","journal-title":"Case Rep Oncol"},{"key":"key-10.4103\/0973-1482.172575-25","first-page":"e27","volume-title":"Sunitinib- and sorafenib-induced nephrotic syndrome in a patient with gastrointestinal stromal tumor","author":"Turan","year":"2012","journal-title":"Ann Pharmacother"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:28:29Z","timestamp":1786714109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0973-1482.172575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["172575"],"URL":"https:\/\/doi.org\/10.4103\/0973-1482.172575","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}